
JHTV Bringing The Benefits of Academic Discovery to the World.
Our Mission & Vision
JHTV aims to maximize the impact of Johns Hopkins University’s research excellence by facilitating the translation and commercialization of discoveries into accessible technologies, products and services that benefit society.
A Decade of Success
Since 2014, JHTV has been advancing innovation ecosystems and developing tomorrow's solutions for today's biggest challenges. Explore the past decade of success through our Celebrating 10 Years of Innovation page below.
EMC2 Bio

Leveraging world-leading expertise from the fields of immunology, beta cell biology, materials science and immuno-oncology to transform the treatment of Type 1 Diabetes, EMC2 Bio is developing an antibody-nanoparticle conjugate (ANC) designed to target genetic cargo specifically to pancreatic β cells. The cargo will target gene networks that modulate the interactive crosstalk between the β cell and the immune system in ways that protect the β cell from immune detection and destruction, by engaging the same mechanisms employed by cancer cells to escape immune surveillance. EMC2 Bio is initiating a seed financing to accelerate the completion of key IND-supporting preclinical experiments and activities. Contact Melissa Stundick for more information.
